PRKAR1A and histiocytic sarcoma: Mice bearing a transgene expressing an anti-sense Prkar1a construct (AS-Prkar1a) developed more tumors than the Prkar1a+/− mice, including adrenal hyperplasia, histiocytic sarcomas (HS) and lymphomas [9].